Insights On Outsourced Drug Development
-
Middle-Up Mass Analysis Of Protease Digested Cetuximab
10/24/2022
Explore a complete reversed phase UHPLC-MS workflow, developed to simplify middle-up mass analysis of an immunoglobulin G antibody, from the antibody purification, proteolysis, and reduction to its UHPLC-MS analysis.
-
Bench To Bedside: A Scalable End-To-End Solution For AAV Production
8/30/2022
How to efficiently translate bench-scale processes to commercial GMP manufacturing to produce viral vectors at the scale needed to meet dosage requirements.
-
What Is The FusionOptics Technology?
1/8/2024
Learn about stereo microscopes that combine high resolution and depth of field to provide a superior 3D perception of samples.
-
CDMO Supports Complex Bispecific Antibody Development
4/13/2022
Read how the expertise, resources and flexibility of one partner have been fundamental in advancing novel and complex bispecific antibody candidates that target the WNT pathway.
-
Pursuing Venture Philanthropy With Opus Genetics: The Business Of Biotech
8/10/2022
Explore new, more agile approaches to overcoming the advanced therapy obstacles inherent to bringing rare disease treatments to market.
-
Nasal Vaccine Development, Manufacturing, And Device Selection
7/11/2023
When developing a nasal delivery program, a partner with experience in development and manufacturing techniques who can see a program through small-scale clinical to commercial supply is crucial.
-
Taste Masking 101: Sensory And Performance Evaluation
7/11/2022
Learn how techniques and innovations in taste masking sensory and performance evaluation can help accelerate your formulation development and confirm desired taste profile.
-
In-Process Media Monitoring Using LC-MS And Automated High Throughput Microbioreactor Systems
8/23/2022
Explore a comprehensive LC-MS methodology, workflow, and batch analysis software that allows bioprocessing engineers to quickly and easily run and process large number of samples.
-
Evaluation Of Influenza Production In MDCK CD Medium
8/29/2022
Learn more about the production benefits imposed using MDCK cells that have the potential to significantly reduce lead times for vaccine production and alleviate constraints on raw material supply.
-
Protecting Human Health With Organ-On-A-Chip Technology
3/1/2024
Explore compelling evidence that suggests Organ-on-a-Chip technology offers a far more reliable means of predicting drug toxicity than traditional animal models.